These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 31436702)

  • 21. Assessment of chronic hepatitis B: the importance of hepatitis B virus DNA testing.
    Croagh CM; Bell SJ; Locarnini S; Desmond PV
    Intern Med J; 2012 Feb; 42(2):170-5. PubMed ID: 21241443
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of relationship between histopathological, serological and biochemical parameters in patients with chronic hepatitis B infection.
    Diktas H; Karacaer Z; Özturk II; Cicek H
    Postgrad Med J; 2016 Dec; 92(1094):693-696. PubMed ID: 27170311
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Spontaneous increases in alanine aminotransferase levels in asymptomatic chronic hepatitis B virus-infected patients.
    Kumar M; Chauhan R; Gupta N; Hissar S; Sakhuja P; Sarin SK
    Gastroenterology; 2009 Apr; 136(4):1272-80. PubMed ID: 19208347
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decreasing hepatitis B viral load is associated with a risk of significant liver fibrosis in hepatitis B e antigen positive chronic hepatitis B.
    Xie Q; Hu X; Zhang Y; Jiang X; Li X; Li J
    J Med Virol; 2014 Nov; 86(11):1828-37. PubMed ID: 25145769
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The importance of the serum quantitative levels of hepatitis B surface antigen and hepatitis B e antigen in children with chronic hepatitis B.
    Demirören K; Kocamaz H; Doğan Y
    Turk J Gastroenterol; 2015 Jan; 26(1):36-41. PubMed ID: 25698269
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A large population study of spontaneous HBeAg seroconversion and acute exacerbation of chronic hepatitis B infection: implications for antiviral therapy.
    Yuen MF; Yuan HJ; Hui CK; Wong DK; Wong WM; Chan AO; Wong BC; Lai CL
    Gut; 2003 Mar; 52(3):416-9. PubMed ID: 12584226
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Chronic hepatitis B virus (HBV) infection: usefulness of the combination of HBeAg and ALT determination to predict a high HBV-DNA level and therefore the necessity of referral to a specialist for possible antiviral treatment].
    Veldhuijzen IK; Mostert MC; Niesters HG; Richardus JH; de Man RA
    Ned Tijdschr Geneeskd; 2008 Jun; 152(25):1426-30. PubMed ID: 18624006
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis B virus genotypes and G1896A precore mutation in 486 Spanish patients with acute and chronic HBV infection.
    Rodriguez-Frias F; Jardi R; Buti M; Schaper M; Hermosilla E; Valdes A; Allende H; Martell M; Esteban R; Guardia J
    J Viral Hepat; 2006 May; 13(5):343-50. PubMed ID: 16637866
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combination of baseline parameters and on-treatment hepatitis B virus DNA levels to start and continue patients with lamivudine therapy.
    Yuen MF; Fung J; Seto WK; Wong DK; Yuen JC; Lai CL
    Antivir Ther; 2009; 14(5):679-85. PubMed ID: 19704171
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pretherapy alanine transaminase level as a determinant for hepatitis B e antigen seroconversion during lamivudine therapy in patients with chronic hepatitis B. Asian Hepatitis Lamivudine Trial Group.
    Chien RN; Liaw YF; Atkins M
    Hepatology; 1999 Sep; 30(3):770-4. PubMed ID: 10462384
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Failure of therapeutic vaccination using hepatitis B surface antigen vaccine in the immunotolerant phase of children with chronic hepatitis B infection.
    Dikici B; Bosnak M; Ucmak H; Dagli A; Ece A; Haspolat K
    J Gastroenterol Hepatol; 2003 Feb; 18(2):218-22. PubMed ID: 12542609
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Serum ALT and HBV DNA levels in patients with HBeAg-negative chronic hepatitis B].
    Kim KH; Na IH; Cha JM; Cho YK; Park SY; Kim HP; Song CS; Heo J; Cho M
    Taehan Kan Hakhoe Chi; 2003 Dec; 9(4):284-92. PubMed ID: 14695695
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical significance of hepatitis B virus precore and core promoter variants in Korean patients with chronic hepatitis B.
    Yim SY; Um SH; Young Jung J; Kim TH; Kim JD; Keum B; Seo YS; Yim HJ; Jeen YT; Lee HS; Chun HJ; Kim CD; Ryu HS
    J Clin Gastroenterol; 2015 Jan; 49(1):61-8. PubMed ID: 24406435
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HBeAg-negative chronic hepatitis patients should be monitored more strictly: a cross-sectional retrospective study on antiviral treatment-naïve patients.
    Zeng DW; Dong J; Zhang JM; Zhu YY; Jiang JJ; Liu YR
    J Med Virol; 2015 Oct; 87(10):1682-8. PubMed ID: 25965250
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term outcome of hepatitis B e antigen-negative hepatitis B surface antigen carriers in relation to changes of alanine aminotransferase levels over time.
    Tai DI; Lin SM; Sheen IS; Chu CM; Lin DY; Liaw YF
    Hepatology; 2009 Jun; 49(6):1859-67. PubMed ID: 19378345
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distribution and clinical characteristics of patients with chronic hepatitis B virus infection in the grey zone.
    Yao K; Liu J; Wang J; Yan X; Xia J; Yang Y; Wu W; Liu Y; Chen Y; Zhang Z; Li J; Huang R; Wu C
    J Viral Hepat; 2021 Jul; 28(7):1025-1033. PubMed ID: 33797145
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combination of Entecavir/Peginterferon Alfa-2a in Children With Hepatitis B e Antigen-Positive Immune Tolerant Chronic Hepatitis B Virus Infection.
    Rosenthal P; Ling SC; Belle SH; Murray KF; Rodriguez-Baez N; Schwarzenberg SJ; Teckman J; Lin HS; Schwarz KB;
    Hepatology; 2019 Jun; 69(6):2326-2337. PubMed ID: 30318613
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Longitudinal changes in serum HBV DNA levels and predictors of progression during the natural course of HBeAg-negative chronic hepatitis B virus infection.
    Papatheodoridis GV; Chrysanthos N; Hadziyannis E; Cholongitas E; Manesis EK
    J Viral Hepat; 2008 Jun; 15(6):434-41. PubMed ID: 18194171
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Short-term lamivudine therapy in HBeAg-negative chronic active hepatitis B in Taiwan.
    Chien RN; Liaw YF
    Antivir Ther; 2006; 11(7):947-52. PubMed ID: 17302259
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HBeAg/anti-HBe, alanine aminotransferase and HBV DNA levels in HBsAg positive chronic carriers.
    Rabbi FJ; Rezwan MK; Shirin T
    Bangladesh Med Res Counc Bull; 2008 Aug; 34(2):39-43. PubMed ID: 19119537
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.